No abstract available
MeSH terms
-
Age Factors
-
Antineoplastic Agents / therapeutic use
-
DNA Mutational Analysis
-
Disease-Free Survival
-
Genetic Predisposition to Disease
-
Humans
-
Melanoma / drug therapy
-
Melanoma / enzymology
-
Melanoma / genetics*
-
Melanoma / mortality
-
Melanoma / pathology
-
Mutation*
-
Phenotype
-
Protein Kinase Inhibitors / therapeutic use
-
Proto-Oncogene Proteins B-raf / antagonists & inhibitors
-
Proto-Oncogene Proteins B-raf / genetics*
-
Proto-Oncogene Proteins B-raf / metabolism
-
Risk Assessment
-
Risk Factors
-
Skin Neoplasms / drug therapy
-
Skin Neoplasms / enzymology
-
Skin Neoplasms / genetics*
-
Skin Neoplasms / mortality
-
Skin Neoplasms / pathology
-
Time Factors
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Protein Kinase Inhibitors
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf